Gun-Hwa Kim,Soohyun Kim,Jong-Soon Choi,Seung II Kim,Edmond Changkyun Park
申请号:
US14178090
公开号:
US20140275198A1
申请日:
2014.02.11
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver, and more specifically relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver containing a CYP4A (cytochrome P450A) inhibitor as an active ingredient. According to the present invention, the CYP4A inhibitor suppresses endoplasmic reticulum stress, reduces the blood insulin concentration and suppresses apoptosis of liver cells, and hence exhibits effects in preventing or treating diabetes or fatty liver.